Molecular pathology in the diagnosis of hematologic neoplasia

APMIS

Volumn 105, Issue 12, 1997, Pages 895-903

  Sambade, Clara ^a,b   Sällström, Jan F ^a   Sundström, Christer ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Diagnosis; Genetics; Leukemia; Lymphoma; Prognosis

Indexed keywords

CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENETIC ANALYSIS; HUMAN; LEUKEMIA; LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

EID: 0031442797     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb05100.x     Document Type: Review

References (71)

1. Achille, A., Scarpa, A., Montresor, M., Scardoni, M., Zamboni, G., Chilosi, M., Capelli, P., Franzin, G. & Menestrina, F.: Routine application of polymerase chain reaction in the diagnosis of monoclonality of B-cell lymphoid proliferations. Diagn. Mol. Pathol. 4: 14-24, 1995.
2. Beishuizen, A., Verhoeven, M.-A. J., Mol, E. J., Breit, T. M., Wolvers-Tettero, I. L. M. & van Dongen, J. J. M.: Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: Recommendations for optimal results. Leukemia 7: 2045-2053, 1993.
3. Bloomfield, C. D., Goldman, A. I., Alimena, G., Berger, R., Borgström, G. H., Brandt, L., Catovsky, D. et al.: Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 67: 415-420, 1986.
4. Boer, C. J. de, Schuuring, E., Dreef, E., Peters, G., Bartek, J., Kluin, P. M. & van Krieken, J. H. J. M.: Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 86: 2715-2723, 1995.
5. Bourguin, A., Tung, R., Galili, N. & Sklar, J.: Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms. Proc. Natl. Acad. Sci. USA 87: 8536-8540, 1990.
6. Brisco, M. J., Condon, J., Hughes, E., Neoh, S. H., Nicholson, I., Sykes, P. J., Tauro, G., Ekert, H., Waters, K., Toogood, I., Seshadri, R., Morley, A. & the Australian and New Zealand Children's Cancer Study Group: Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Leukemia 7: 1514-1520, 1993.
7. Campana, D. & Pui, C.-H.: Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 85: 1416-1434, 1995.
8. Cayuela, J.-M., Madani, A., Sanhes, L., Stern, M.-H. & Sigaux, F.: Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood 87: 2180-2186, 1996.
9. Chim, J. C., Coyle, L. A., Yaxley, J. C., Cole-Sinclair, M. F., Cannell, P. K, Hoffbrand, V. A. & Foroni, L.: The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL. Br. J. Haematol. 92: 104-115, 1996.
10. Chleq-Dechamps, C. M., LeBrun, D. P., Huie, P., Besnier, D. P., Warnke, R. A., Sibley, R. K & Cleary, M. L.: Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. Blood 81: 293-298, 1993.
11. Costello, R. T., Kirk, J. & Gabert, J.: Value of PCR analysis for long term survivors after allogeneic bone marrow transplant for chronic myelogenous leukemia: a comparative study. Leuk. Lymphoma 20: 239-243, 1996.
12. Cross, N. C. P.: Quantitative PCR techniques and applications. Br. J. Haematol. 89: 693-697, 1995.
13. Diaz-Cano, S.: PCR-based alternative for diagnosis of immunoglobulin heavy chain gene rearrangement. Principles, practice, and polemics. Diagn. Mol. Pathol. 5: 3-9, 1996.
14. Drexler, H. C., Borkhardt, A. & Janssen, J. W.: Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction. Leuk. Lymphoma 19: 359-380, 1995.
15. Gibson, U. E. M., Heid, C. A. & Williams, P. M.: A novel method for real time quantitative RT-PCR. Genome Res. 6: 995-1001, 1996.
16. Gordon, M. Y. & Goldman, J. M. : Cellular and molecular mechanisms in chronic myeloid leukaemia: Biology and treatment. Br. J. Haematol. 95: 10-20, 1996.
17. Griesser, H., Tkachuc, D., Reis, M. & Mak, T. W.: Gene rearrangements and translocations in lymphoproliferative disease. Blood 73: 1402-1415, 1989.
18. Hansen-Hagge, T. E., Yokota, S. & Bartram, C. R.: Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor δ chain sequences. Blood 74: 1762-1767, 1989.
19. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K., Cleary, M. L., Delsol, G., De Wolf Peeters, C., Falini, B., Gatter, K. C. et al.: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361-1392, 1994.
20. Heid, C. A., Stevens, J., Livak, K. J. & Williams, P. M.: Real time quantitative PCR. Genome Res. 6: 986-994, 1996.
21. Herbst, H., Tippelmann, G., Anagnostopoulos, I., Gerdes, J., Schwarting, R., Boehm, T. Pileri, S., Jones, D. B. & Stein, H.: Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: Dissociation between phenotype and genotype. Leuk. Res. 13: 103-116, 1989.
22. Hirama, T. & Koeffler, H. P.: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841-854, 1995.
23. Hummel, M., Ziemann, K, Lammert, H., Pileri, S., Sabattini, E. & Stein, H.: Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N. Engl. J. Med. 333: 901-906, 1995.
24. Joos, S., Fink, T. M, Ratsch, A. & Lichter, P.: Mapping and chromosome analysis: the potential of fluorescence in situ hybridization. J. Biotechnol. 35: 135-153, 1994.
25. Kneba, M., Bolz, I., Linke, B. & Hiddemann, W.: Analysis of rearranged T-cell receptor b-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis. Blood 86: 3930-3937, 1995.
26. Knechtli, C. J. C., Goulden, N. J., Langlands, K. & Potter, M. N.: The study of minimal residual disease in acute lymphoblastic leukemia. J. Clin. Pathol.: Mol. Pathol. 48: M65-M73, 1995.
27. Knowles, D. M., Cesarman, E., Chadburn, A., Frizzera, G., Chen, J., Rose, E. A. & Michler, R. E.: Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85: 552-565, 1995.
28. Korsmeyer, S. J.: Antigen receptor genes as molecular markers of lymphoid neoplasms. J. Clin. Invest. 79: 1291-1295, 1987.
29. Kramer, M. H., Raghoebier, S., Beverstock, G. C., de Jong, D., Kluin, P. M. & Kluin-Nelemans, J. C.: De novo acute B-cell leukemia with translocation t(14; 18): an entity with a poor prognosis. Leukemia 5: 473-478, 1991.
30. Krishnan, J., Wallberg, K. & Frizzera, G.: T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness. Am. J. Surg. Pathol. 18: 455-465, 1994.
31. Küppers, R., Rajewsky, K., Zhao, M., Somons, G., Laumann, R., Fischer, R. & Hansmann, M.-L.: Hodgkin's disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc. Natl. Acad. Sci. USA 91: 10962-10966, 1994.
32. Ladanyi, M., Offit, K., Parsa, N. Z., Condon, M. R., Chekka, N., Murphy, J. P., Filippa, D. A., Jhanwar, S. C., Dalla-Favera, R. & Chaganti, R. S.: Follicular lymphoma with t(8;14) (q24;q32): a distinct clinical and molecular subset of t(8;14)-bearing lymphomas. Blood 79: 2124-2130, 1992.
33. Landegren, U.: Ligation-based DNA diagnostics. Bioessays 15: 761-765, 1993.
34. Lo Coco, F., Gaidano, G., Louie, D. C., Offit, K., Chaganti, R. S. K. & Dalla-Favera, R.: p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82: 2289-2295, 1993.
35. Macintyre, E. A., d'Auriol, L., Duparc, N., Leverger, G., Galibert, F. & Sigaiux, F.: Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias. J. Clin. Invest. 86: 2125-2135, 1990.
36. Macon, W. R., Williams, M. E., Greer, J. P., Stein, R. S., Collins, R. D. & Cousar, J. B.: T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases. Am. J. Surg. Pathol. 16: 351-363, 1992.
37. Malcomson, R. D. G., McGullogh, C. T., Bruce. D. J. & Harrison, D. J.: The scope of quantitative polymerase chain reaction assays in clinical molecular pathology. J. Clin. Pathol.: Mol. Pathol. 48: M178-M183, 1995.
38. McBride, J. A., Rodriguez, J., Luthra, R., Ordonez, N. G., Cabanillas, F. & Pugh, W. C.: T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am. J. Surg. Pathol. 20: 193-201, 1996.
39. Medeiros, L. J.: Molecular Hematopathology. In: Weiss, L. M. (Ed.): Pathology of Lymph Nodes. Churchill Livingstone, Inc., 1996, pp. 1-80.
40. Menke, M. A., Tiemann, M., Vogelsang, D., Boie, C. & Parwaresch, R.: Temperature gradient gel electrophoresis for analysis of a polymerase chain reaction-based diagnostic clonality assay in the early stages of cutaneous T-cell lymphomas. Electrophoresis 16: 733-738, 1995.
41. Miettinen, M., Fletcher, C. D. & Lasota, J.: True histiocytic lymphoma of small intestine. Analysis of two S-100 protein-positive cases with features of interdigitating reticulum cell sarcoma. Am. J. Clin. Pathol. 100: 285-292, 1993.
42. Morgan, G. J., Shiach, C. & Potter, M.: The clinical value of detecting gene rearrangements in acute leukaemias. Br. J. Haematol. 88: 459-464, 1994.
43. Nichols, J. & Nimer, S. D.: Transcription factors, translocations, and leukemia. Blood 80: 2953-2963, 1992.
44. O'Connor, N. T., Stein, H., Gatter, K. C., Wainscoat, J. S., Crick, J., Al-Saati, T., Falini, B., Delsol, G. & Mason, D. Y.: Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology 11: 733-740, 1987.
45. Offit, K., Lo Coco, F., Louie, D. C., Parsa, N. Z., Leung, D., Portlock, C., Ye, B. H., Lista, F., Filippa, D. A., Rosenbaum, A. et al: Rearrangement of the BCL-6 gene as a prognostic marker in diffuse large-cell lymphoma. N. Engl. J. Med. 331: 74-80, 1994.
46. Ouspenskaia, M. V., Johnston, D. A., Roberts, M., Estrov, Z. & Zipf, T. F.: Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia 9: 321-328, 1995.
47. Plas, D. C. van der, Grosveld, G. & Hagemeijer, A.: Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. Cancer Genet. Cytogenet. 52: 143-156, 1991.
48. Potter, M. N., Cross, M. C., van Dongen, J. J., Saglio, G., Oakhill, A., Bartram, C. R. & Coldman, J. M.: Molecular evidence of minimal residual disease after treatment for leukemia and lymphoma: an updated meeting report and review. Leukemia 7: 1302-1314, 1993.
49. Rabbits, T. H.: Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 67: 641-644, 1991.
50. Rabbits, T. H.: Chromosomal translocations in human cancer. Nature 372: 143-149, 1994.
51. Raelson, J. V., Nervi, C., Rosenauer, A., Benedetti, L. Monczak, Y., Pearson, M., Pelicci, P. G. & Miller Jr., W. H.: The PML/RARa oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 88: 2826-2832, 1996.
52. Ralfkiaer, E., Delsol, G., O'Connor, N. T., Brandtzaeg, P., Brousset, P., Vejlsgaard, G. L. & Mason, D. Y.: Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J. Pathol. 160: 9-17, 1990.
53. Roberts, W. M., Estrov, Z., Kitchingman, G. R. & Zipf, T. F.: The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification of antigen-receptor gene sequences. Leuk. Lymphoma 20: 181-197, 1996.
54. Romana, S. P., Poirel, H., Leconiat, M., Flexor, M.-A., Mauchauffe, M., Jonveaux, P., Macintyre, E. A., Berger, R. & Bernard, O. A.: High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86: 4263-4269, 1995.
55. Rowley, J. D., Aster, J. C. & Sklar, J.: The impact of new DNA diagnostic technology on the management of cancer patients. Survey of diagnostic techniques. Arch. Pathol. Lab. Med. 117: 1104-1109, 1993.
56. Rubnitz, J. E., Behm, F. G. & Downing, J. R.: 11q23 rearrangements in acute leukemia. Leukemia 10: 74-82, 1996.
57. Scholten, C., Födinger, M., Mitterbauer, M. & Laczika, K. et al.: Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia. Ann. Hematol. 71: 155-160, 1995.
58. Shiach, C. R., Evans, P. A., Short, M. A., Bailey, C., C., Lewis, I. J. & Kinsey, S. E.: Detection and accurate sizing of PCR-product by automated scanning: Improved detection of immunoglobulin gene rearrangements in ALL. Br. J. Haematol. 85: 431-3, 1993.
59. NP/ALK: a distinct clinicopathologic entity. Blood 86: 1954-1960, 1995.
60. Siebert, P. D. & Larrick, J. W.: Competitive PCR. Nature 359: 557-558, 1992.
61. Swerdlow, S. H., Zukerberg, L. R., Yang, W.-I., Harris, N. L. & Williams, M. E.: The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements. Am. J. Surg. Pathol. 20: 627 640, 1996.
62. Tamaru, J., Hummel, M., Zemlin, M., Kalvelage, B. & Stein, H.: Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutation in the VH genes. Blood 84: 708-715, 1994.
63. Thunberg, U., Alemi, M., Sundström, C. & Sällström, J. F.: Non-radioactive detection of monoclonal immunoglobulin heavy chain gene rearrangement with PCR-SSCP. Haematol. Pathol. 9: 141-153, 1995.
64. Thunberg, U., Sällström, J. F., Frost, B.-M., Lönnerholm, G. & Sundström, C: PCR-SSCP analysis of antigen receptor rearrangements in monitoring therapeutic effect in childhood ALL. Submitted to Leukemia 1997.
65. Weiss, L. M. & Chang, K. L.: Molecular biologic studies of Hodgkin's disease. Semin. Diagn. Pathol. 9: 272-278, 1992.
66. Willman, C. L. & Whittaker, M. H.: The molecular biology of acute myeloid leukemia. Proto-oncogene expression and function in normal and neoplastic myeloid cells. Clin. Lab. Med. 10: 769-796, 1990.
67. Yano, T., van Krieken, J. H., Magrath, I. T., Longo, D. L., Jaffe, E. S. & Raffeld, M.: Histogenetic correlations between subcategories of small non-cleaved cell lymphomas. Blood 79: 1282-1290, 1992a.
68. Yano, T., Jaffe, E. S., Longo, D. L. & Raffeld, M.: MYC rearrangements in histologically progressed follicular lymphomas. Blood 80: 758-767, 1992b.
69. Yatabe, Y., Nakamura, S., Seto, M., Kuroda, H., Kagami, Y., Suzuki, R., Ogura, M., Kojima, M., Koshikawa, T., Ueda, R. & Suchi, T.: Clinicopathologic study of PRADI/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity. Am. J. Surg. Pathol. 20: 1110-1122, 1996.
70. Zeleznik-Le, N. J., Nucifora, G. & Rowley, J. D.: The molecular biology of myeloproliferative disorders as revealed by chromosomal abnormalities. Semin. Hematol. 32: 201-219, 1995.
71. Zelickson, B. D., Peters, M. S. & Pittelkow, M. R.: Gene rearrangement analysis in lymphoid neoplasia. Clin. Dermatol. 9: 119-128, 1991.